Home

Bafna Pharmaceuticals PE Ratio

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PE

28.2

Last updated on: Jun 19, 2025

Key Highlights

  • The P/E Ratio of Bafna Pharmaceuticals Ltd is 28.2 as of 19 Jun 15:30 PM .
  • The P/E Ratio of Bafna Pharmaceuticals Ltd is 0 as of March 2020 .
  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 75 as of 19 Jun 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 8.8. The PE Ratio of Finance industry is 31.4. The PE Ratio of IT - Software industry is 25.8. The PE Ratio of Pharmaceuticals industry is 56.6. The PE Ratio of Retail industry is 124.6. The PE Ratio of Textiles industry is 9.9 in 2025.
Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PE

-

Last updated on: Invalid Date

Company Fundamentals for Bafna Pharmaceuticals Ltd

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Share Price

₹ 75

0.00 (0.00%)

stock direction

Last updated on: Jun 19, 2025

Market Price of Bafna Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Jun 202575
17 Jun 202574.51
16 Jun 202576
13 Jun 202574.27
12 Jun 202574.41
11 Jun 202575
10 Jun 202573.1
09 Jun 202575
06 Jun 202573
05 Jun 202574.5

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Bafna Pharmaceuticals Ltd

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Bafna Pharmaceuticals Ltd177.42
Sun Pharmaceutical Industries Ltd395326
Divis Laboratories Ltd173562
Cipla Ltd121023
Dr Reddys Laboratories Ltd109551
Torrent Pharmaceuticals Ltd109200

PE Ratio of Bafna Pharmaceuticals Ltd Explained

177.42

Market cap

4

Earnings

28.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bafna Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Bafna Pharmaceuticals Ltd

No data available

* All values are in %

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

Bafna Pharmaceuticals Ltd News Hub

Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter

Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains

Read more

13 Aug 24

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

10 Aug 24

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on

Read more

04 Sept 24

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on

Read more

05 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bafna Pharmaceuticals Ltd

What is the current PE Ratio of Bafna Pharmaceuticals Ltd?

The Current PE Ratio of Bafna Pharmaceuticals Ltd is 28.2 as on 19 Jun 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 56.6 as on 19 Jun 2025.

What was the PE Ratio of Bafna Pharmaceuticals Ltd last year?

The PE Ratio of Bafna Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 28.2, showing a year-on-year growth of -%.

What does the PE Ratio of Bafna Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Bafna Pharmaceuticals Ltd is 28.2. This ratio indicates that investors are willing to pay 28.2 times the earnings per share for each share of Bafna Pharmaceuticals Ltd.

What is the PE Ratio Growth of Bafna Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bafna Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -72.2.

How does the PE ratio of Bafna Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Bafna Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Bafna Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Bafna Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Bafna Pharmaceuticals Ltd PE Ratio?

The PE ratio of Bafna Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Bafna Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Bafna Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Bafna Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Bafna Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Bafna Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Bafna Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Bafna Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Bafna Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions